Astrana Health Stock Hits Day Low of $25.54 Amid Price Pressure

Astrana Health, Inc. experienced significant volatility on November 7, 2025, with the stock declining by 23.46% and hitting an intraday low of USD 25.54. This sharp drop highlights ongoing challenges for the small-cap company, which operates within the miscellaneous industry.
Over the past year, Astrana Health has underperformed the broader market, with a staggering decline of 56.78%, while the S&P 500 has gained 12.65%. The company's financial metrics reveal a mixed picture; despite a high return on equity (ROE) of 19.00%, its recent performance has been marred by negative results over the last four quarters. The net profit for the half-year stood at USD 16.13 million, reflecting a decline of 51.79%.

Additionally, Astrana Health's debt-to-equity ratio remains low at 0.10, indicating a conservative approach to leverage. However, the stock's price-to-book ratio of 2.16 suggests it is trading at a premium compared to historical valuations. Institutional holdings are notable at 58.26%, with a slight increase of 1.77% in the last quarter, indicating some level of confidence among larger investors despite the recent downturn.